SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,753,755 | -16.3% | 3,968,588 | -5.0% | 1.95% | -1.8% |
Q2 2023 | $109,562,577 | -5.4% | 4,178,588 | -7.1% | 1.98% | -12.7% |
Q1 2023 | $115,801,686 | -15.2% | 4,498,900 | -14.3% | 2.27% | -13.0% |
Q4 2022 | $136,552,500 | -13.4% | 5,250,000 | -5.0% | 2.61% | -10.8% |
Q3 2022 | $157,655,000 | +6.2% | 5,525,926 | -8.3% | 2.93% | +8.9% |
Q2 2022 | $148,417,000 | -56.4% | 6,028,307 | 0.0% | 2.69% | -51.3% |
Q1 2022 | $340,238,000 | -8.9% | 6,028,307 | 0.0% | 5.52% | +14.9% |
Q4 2021 | $373,634,000 | -2.3% | 6,028,307 | 0.0% | 4.80% | +14.3% |
Q3 2021 | $382,436,000 | -23.2% | 6,028,307 | -0.3% | 4.20% | -16.6% |
Q2 2021 | $498,108,000 | +9.4% | 6,044,266 | -2.3% | 5.04% | +18.4% |
Q1 2021 | $455,127,000 | -15.3% | 6,186,307 | -16.5% | 4.26% | -9.4% |
Q4 2020 | $537,105,000 | +52.1% | 7,406,307 | 0.0% | 4.70% | +5.9% |
Q3 2020 | $353,059,000 | +13.5% | 7,406,307 | 0.0% | 4.44% | +1.3% |
Q2 2020 | $311,065,000 | +55.6% | 7,406,307 | 0.0% | 4.38% | +30.3% |
Q1 2020 | $199,970,000 | -29.9% | 7,406,307 | 0.0% | 3.36% | -17.4% |
Q4 2019 | $285,069,000 | +77.5% | 7,406,307 | 0.0% | 4.07% | +33.6% |
Q3 2019 | $160,569,000 | – | 7,406,307 | – | 3.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |